In Brief: Bristol-Myers Squibb's Cefzil
Executive Summary
Bristol-Myers Squibb's Cefzil: Cefprozil tablets and suspension add new indication Sept. 5 for treatment of acute sinusitis caused by S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis...